Abstract
Background and objectiveThe coronavirus disease 2019 (COVID-19) outbreak, which was first detected in Wuhan, China, has turned into a rapidly spreading global healthcare crisis. The clinical and laboratory features of COVID-19 are associated with significant regional variations. In this study, we aimed to describe the clinical and demographic profile of COVID-19 patients from a tertiary care hospital in Northeast India.Materials and methodsThis was a hospital-based cross-sectional study that included all laboratory-confirmed COVID-19 cases admitted to the institution from 1st July to 31st October 2020. The information was collected on a predesigned proforma, which included patients' demographic profiles, clinical presentations, and outcomes as per treatment by trained doctors.ResultsThe study included 180 laboratory-confirmed COVID-19 cases. A history of contact with laboratory-confirmed COVID-19-affected individuals was found in 92 (51.1%) patients. The median age of the patients was 37.17 years (range: 18-80 years), and there were 104 (57.78%) males in the cohort. Of the total enrolled patients, 102 (56.67%) were asymptomatic from the time of exposure till their admission. The common presenting complaints were fever (n=55, 70.51%), cough (n=42, 53.85%), and shortness of breath (n=32, 42.02%). The case fatality rate among the admitted cases was 15%. Comorbidities were found in 84 (46.67%) patients with the most common one being diabetes mellitus (n=31, 36.9%) followed by hypertension (n=29, 34.52%). Patients with advanced age (more than 60 years) and coexisting comorbidities were at higher risk of progression of disease and death.ConclusionThe COVID-19 pandemic is not only a huge burden on healthcare facilities but also a significant cause of disruption in societies globally. The majority of the patients with COVID-19 infection presenting to our hospital were young and asymptomatic. Patients of advanced age with comorbidities were found to have more complications. An analysis of the trends related to COVID-19 in different hospital and institutional settings will help to achieve better preparedness and lead to improved patient care to combat the COVID-19 pandemic in a more efficient manner.
Highlights
Coronavirus disease 2019 (COVID-19) is a viral pneumonia caused by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
SARS-CoV-2 belongs to the same family of viruses as the causative agents of the other two recent outbreaks of viral pneumonia: severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS)
We focused on comorbidities associated with COVID-19 patients, which can help clinicians in early screenings of high-risk patients and judicious utilization of healthcare resources among these patients to prevent the more severe disease
Summary
Coronavirus disease 2019 (COVID-19) is a viral pneumonia caused by a novel coronavirus (novel CoV) called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). How to cite this article Jamil M, Bhattacharya P K, Barman B, et al (October 19, 2021) Clinical and Demographic Profile of COVID-19 Patients: A Tertiary Level HospitalBased Study From Northeast India. Even though COVID-19 has affected all regions of the world, there are great variations in the prevalence of the disease and mortality rates in different countries, the reasons for which are poorly understood. The coronavirus disease 2019 (COVID-19) outbreak, which was first detected in Wuhan, China, has turned into a rapidly spreading global healthcare crisis. We aimed to describe the clinical and demographic profile of COVID-19 patients from a tertiary care hospital in Northeast India
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
